Mabpharm Limited (2181) announced information regarding its Board of Directors and committee memberships as of October 31, 2025. The Board includes both executive and non-executive members, with leadership roles clearly defined. Chairman responsibilities rest with a non-executive member, while the Chief Executive Officer role is held by an executive member.

The company has organized three committees with established terms of reference. The Audit Committee is chaired by an independent non-executive member and includes representatives from non-executive and independent non-executive ranks. The Remuneration Committee is similarly led by an independent non-executive board member, joined by one executive director and another independent non-executive member. The Nomination Committee leadership is undertaken by an independent non-executive member, supported by both executive and independent non-executive directors.